These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4083865)

  • 1. Pharmacokinetics and dosage requirements of netilmicin in cystic fibrosis patients.
    Bosso JA; Townsend PL; Herbst JJ; Matsen JM
    Antimicrob Agents Chemother; 1985 Dec; 28(6):829-31. PubMed ID: 4083865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and sputum concentrations of netilmicin in combination with acylureidopenicillin and cephalosporins in clinical treatment of pulmonary exacerbations in cystic fibrosis.
    Hjelte L; Malmborg AS; Strandvik B
    J Antimicrob Chemother; 1989 Jun; 23(6):885-90. PubMed ID: 2503488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of netilmicin in children with and without cystic fibrosis.
    Michalsen H; Bergan T
    Antimicrob Agents Chemother; 1981 Jun; 19(6):1029-31. PubMed ID: 7271272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic assessment of netilmicin in newborns and older children.
    Bergan T; Michalsen H
    Infection; 1982; 10(3):153-8. PubMed ID: 7107013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive treatment of pseudomonas chest infection in cystic fibrosis: a comparison of tobramycin and ticarcillin, and netilmicin and ticarcillin.
    Conway SP; Miller MG; Ramsden C; Littlewood JM
    Acta Paediatr Scand; 1985 Jan; 74(1):107-13. PubMed ID: 3885674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Netilmicin pharmacokinetics in uremic patients undergoing hemodialysis.
    Scatizzi A; Basile C; Strippoli P; Di Maggio A; Orbello G; Lodeserto C; Triarico A; Mingrone G; Longo S; Curino E
    Chemioterapia; 1986 Oct; 5(5):327-9. PubMed ID: 3791480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefazolin and netilmicin serum levels during and after cardiac surgery with cardiopulmonary bypass.
    Lehot JJ; Reverdy ME; Etienne J; Corot C; Nervi C; Sear J; Fleurette J; Estanove S
    J Cardiothorac Anesth; 1990 Apr; 4(2):204-9. PubMed ID: 2131868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of urinary-tract infections with netilmicin (author's transl)].
    Weissbach L; Prehn U; Krasemann C; Gillissen J; Mette U
    Dtsch Med Wochenschr; 1978 Dec; 103(49):1961-5. PubMed ID: 720228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of ticarcillin in patients with cystic fibrosis: a controlled prospective study.
    de Groot R; Hack BD; Weber A; Chaffin D; Ramsey B; Smith AL
    Clin Pharmacol Ther; 1990 Jan; 47(1):73-8. PubMed ID: 2295222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of amikacin in cystic fibrosis: a study of bronchial diffusion.
    Autret E; Marchand S; Breteau M; Grenier B
    Eur J Clin Pharmacol; 1986; 31(1):79-83. PubMed ID: 3780832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance.
    Lanng S; Thorsteinsson B; Røder ME; Nerup J; Koch C
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):217-23. PubMed ID: 7923827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of netilmicin in premature infants.
    Kuhn RJ; Nahata MC; Powell DA; Bickers RG
    Eur J Clin Pharmacol; 1986; 29(5):635-7. PubMed ID: 3956569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of cefepime in cystic fibrosis patients.
    Huls CE; Prince RA; Seilheimer DK; Bosso JA
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1414-6. PubMed ID: 8363368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bolus doses of netilmicin in the treatment of infections of the urinary tract].
    Varese LA; Grazioli F; Antoniola P; Vighetti A; Porcellini G
    G Ital Chemioter; 1985; 32(2):473-6. PubMed ID: 3833588
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of netilmicin and gentamicin pharmacokinetics in humans.
    Chung M; Costello R; Symchowicz S
    Antimicrob Agents Chemother; 1980 Feb; 17(2):184-7. PubMed ID: 7387140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial therapy of Pseudomonas pulmonary exacerbations in cystic fibrosis. A prospective evaluation of netilmicin plus azlocillin versus netilmicin plus ticarcillin.
    Schaad UB; Desgrandchamps D; Kraemer R
    Acta Paediatr Scand; 1986 Jan; 75(1):128-38. PubMed ID: 3082103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a simplified netilmicin dosage regimen in infants.
    Klingenberg C; Småbrekke L; Lier T; Flaegstad T
    Scand J Infect Dis; 2004; 36(6-7):474-9. PubMed ID: 15307571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of azlocillin in children with cystic fibrosis.
    Bergan T; Michalsen H
    Arzneimittelforschung; 1979; 29(12a):1955-7. PubMed ID: 543899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a once-daily netilmicin regimen in the treatment of cystic fibrosis.
    Smith DL; Stableforth DL; Geddes AM
    J Antimicrob Chemother; 1994 Jan; 33(1):191-3. PubMed ID: 8157568
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased dosage requirements of tobramycin and gentamicin for treating Pseudomonas pneumonia in patients with cystic fibrosis.
    Mann HJ; Canafax DM; Cipolle RJ; Daniels CE; Zaske DE; Warwick WJ
    Pediatr Pulmonol; 1985; 1(5):238-43. PubMed ID: 4069813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.